Structure and mechanism of galactose oxidase. The free radical site.

Andrew J. Baron(Howard Hughes Medical Institute), Conrad Stevens(University of Leeds), Carrie M. Wilmot(University of Manchester), Kanjula Seneviratne(University of Leeds), Veronica Blakeley(University of Leeds), David M. Dooley(Howard Hughes Medical Institute), Simon E. V. Phillips(Howard Hughes Medical Institute), Peter F. Knowles(University of Manchester), Michael J. McPherson(University of Manchester)
Journal of Biological Chemistry
October 1, 1994
Cited by 160Open Access
Full Text

Abstract

Crystallographic and spectroscopic studies on galactose oxidase have shown that the active site involves a free radical on tyrosine 272, one of the ligands coordinated to the Cu2+ cofactor. A novel thioether bond between tyrosine 272 and cysteine 228, and a stacking tryptophan 290, over this bond, are features of the crystal structure. The present study describes the development of a high level heterologous expression system for galactose oxidase and the construction of mutational variants at these key active site residues. The expressed wild-type enzyme and mutational variants (W290H and C228G) have been characterized by x-ray crystallography, visible spectroscopy, and catalytic activity measurements. A further variant protein, Y272F, could not be purified. The data establish that the thioether bond and stacking tryptophan are essential for activity and further support a role for tryptophan 290 as a component of the free radical site.


Related Papers

No related papers found

Powered by citation graph analysis